AlzMed

JP

Topics

トピックス
Presented as a finalist at the MedTech Grand Prix Kobe 2021 and received the First Life Holdings Award.
The CEO Shirao contributed to a paper on primary cilia in Alzheimer’s disease neurons, which has been published in the international journal ‘Biochemical and Biophysical Research Communications (BBRC).
Representing Japan, the entrepreneur aiming for global impact in addressing international challenges will be speaking at the world’s largest startup competition, the Extreme Tech Challenge (XTC) World Finals.
1 2